Published in Obstet Gynecol on December 01, 1984
Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause (2008) 2.14
Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2014) 1.45
Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause (2009) 1.04
Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. J Bone Miner Res (2011) 0.95
Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause (2009) 0.94
Perimenopause and cognition. Obstet Gynecol Clin North Am (2011) 0.94
A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause (2012) 0.90
Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2009) 0.89
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Daily salivary cortisol patterns in midlife women with hot flashes. Clin Endocrinol (Oxf) (2016) 0.80
Memory Decline in Peri- and Post-menopausal Women: The Potential of Mind-Body Medicine to Improve Cognitive Performance. Integr Med Insights (2014) 0.75
Ameliorating effect of Erxian decoction combined with Fructus Schisandrae chinensis (Wu Wei Zi) on menopausal sweating and serum hormone profiles in a rat model. Chin Med (2016) 0.75
Hot flashes and midlife symptoms in relation to levels of salivary cortisol. Maturitas (2016) 0.75
Stellate ganglion blockade and verbal memory in midlife women: Evidence from a randomized trial. Maturitas (2016) 0.75
Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms. Menopause (2016) 0.75
[Prevention of secondary manifestations of menopause. Pathophysiologic principles]. Arch Gynecol Obstet (1989) 0.75
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Gynecomastia. N Engl J Med (1980) 2.68
Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med (1999) 2.63
Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril (1999) 2.52
Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man. J Clin Endocrinol Metab (1977) 2.39
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
Biologic effects of transdermal estradiol. N Engl J Med (1986) 2.24
Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol (1999) 2.04
Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology (1993) 2.01
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med (1985) 1.86
Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab (1983) 1.84
Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation (1997) 1.80
The abdominal compartment syndrome is a morbid complication of postinjury damage control surgery. Am J Surg (2001) 1.76
Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab (1974) 1.73
Long-term outcome of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol Metab (1966) 1.72
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab (2001) 1.65
Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (1999) 1.64
Thyroid function in nonthyroidal illnesses. Ann Intern Med (1983) 1.62
Cornual pregnancies in patients with prior salpingectomy undergoing in vitro fertilization and embryo transfer. Fertil Steril (1996) 1.60
Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst (1985) 1.60
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest (1976) 1.58
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab (1982) 1.57
The physiologic basis for anticytokine clinical trials in the treatment of sepsis. J Am Coll Surg (1998) 1.57
Amiodarone and thyroid function. Prog Cardiovasc Dis (1989) 1.55
Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst (1986) 1.54
Effect of calcium carbonate on the absorption of levothyroxine. JAMA (2000) 1.52
Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc (1992) 1.51
Do regular ovulatory cycles increase breast cancer risk? Cancer (1985) 1.50
Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry (1999) 1.49
Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol (1999) 1.48
Feasibility of damage control surgery in the management of military combat casualties. Arch Surg (2000) 1.45
Impotence in scleroderma. Ann Intern Med (1986) 1.44
Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol (1987) 1.42
Response to Slotnich and ortega [Monoamniotic twinning and zone manipulation: a survey of U.S. IVF centers correlating zona manipulation procedures and high-risk twinning frequency (J Assist Reprod Genet 1996; 13:381-385)]. J Assist Reprod Genet (1996) 1.39
Direct evaluation of pituitary thyrotopin reserve utilizing synthetic thyrotopin releasing hormone. J Clin Endocrinol Metab (1971) 1.39
Diastolic hibernation masquerading as constrictive pericarditis. J Card Surg (1998) 1.38
Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1983) 1.36
Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest (1975) 1.36
Thyrotropic action of human chorionic gonadotropin. Thyroid (1995) 1.35
Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol (1982) 1.35
TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol (2004) 1.33
Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol (1974) 1.29
The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab (1992) 1.29
The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A (2001) 1.28
Origin of serum estradiol in postmenopausal women. Obstet Gynecol (1982) 1.28
Utility of the radioimmunoassay of serum thyrotrophin in man. Ann Intern Med (1971) 1.28
Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril (1991) 1.27
Estrogen replacement therapy. Obstet Gynecol (1981) 1.25
Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab (1980) 1.25
Influence of age and sex on plasma calcitonin in human beings. N Engl J Med (1980) 1.23
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab (1981) 1.22
Response to synthetic thyrotropin-releasing hormone in man. J Clin Endocrinol Metab (1970) 1.22
Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology (1989) 1.21
Hydatidiform mole--a cause of clinical hyperthyroidism. Report of two cases with evidence that the molar tissue secreted a thyroid stimulator. N Engl J Med (1971) 1.20
Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol (1980) 1.19
Hypothalamic hypothyroidism. N Engl J Med (1971) 1.19
Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab (1976) 1.18
Dietary calcium intake and rates of bone loss in women. J Clin Invest (1987) 1.17
The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5'-monodeiodination in rats. Endocrinology (1983) 1.17
Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol (2000) 1.16
The aging thyroid. The use of thyroid hormone in older persons. JAMA (1989) 1.16
The TSH response to thyrotropin-releasing hormone (TRH) in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones. J Clin Endocrinol Metab (1976) 1.16
TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol (2006) 1.16
A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res (2001) 1.15
Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril (1991) 1.14
Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab (1986) 1.13
Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology (Berl) (1982) 1.12
Estrogen replacement therapy: indications and complications. Ann Intern Med (1983) 1.11
Cowden disease: gene marker studies and measurements of epidermal growth factor. Am J Hum Genet (1986) 1.10
Do thyroid function tests independently predict survival in the critically ill? Thyroid (1992) 1.10
The thyrotropin in hydatidiform moles is human chorionic gonadotropin. J Clin Endocrinol Metab (1975) 1.09
Association of waking episodes with menopausal hot flushes. JAMA (1981) 1.09
Control of thyrotropin secretion in man. N Engl J Med (1971) 1.09
Attempts to augment thyrotropin secretion. Effects of methimazole, methimazole-iodide, vasopressin, and glucagon. Metabolism (1970) 1.08
LH, FSH and skin temperaure during the menopausal hot flash. J Clin Endocrinol Metab (1979) 1.08
Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med (1977) 1.07
Gonadotropin secretion from a bronchogenic carcinoma. Demonstration by radioimmunoassay. N Engl J Med (1967) 1.07
The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid (2001) 1.06
Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol (1981) 1.06
Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther (2001) 1.05